CNS Aspergillosis: A Downside of Corticosteroid Use
Glucocorticoids are ubiquitously used by physicians for a myriad of diseases. Though powerful and potentially lifesaving, sometimes the dangerous side effects are not at the forefront of our medical decision-making. By immunosuppressing patients, glucocorticoids can place patients at increased risk...
Gespeichert in:
| Veröffentlicht in: | Curēus (Palo Alto, CA) CA), 2024-06, Vol.16 (6), p.e62018 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 6 |
| container_start_page | e62018 |
| container_title | Curēus (Palo Alto, CA) |
| container_volume | 16 |
| creator | Bonagiri, Pranay R Raman, Anjalee Hassan, Sharjeel Ramsey, Andrea |
| description | Glucocorticoids are ubiquitously used by physicians for a myriad of diseases. Though powerful and potentially lifesaving, sometimes the dangerous side effects are not at the forefront of our medical decision-making. By immunosuppressing patients, glucocorticoids can place patients at increased risk for not only the metabolic effects of chronic glucocorticoid use but also increased risk for opportunistic infections. Patients at increased risk include those on prolonged courses or those that require high doses. We report a case of a 34-year-old man who was initiated on glucocorticoids for an unknown rheumatologic disease and presented with generalized weakness, fatigue, nausea, and vomiting. The patient experienced a seizure, which prompted head imaging. A mass was found and eventually biopsied, which was notable for
The patient was initiated on antifungals for CNS aspergillosis and recovered. |
| doi_str_mv | 10.7759/cureus.62018 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11233157</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3077993175</sourcerecordid><originalsourceid>FETCH-LOGICAL-p263t-ae21c3d7e0f6351551da512ae92367c11fb1fc65bdddbdf9738885ac4e3390bd3</originalsourceid><addsrcrecordid>eNpdkM9LwzAUx4MobszdPEvBi5fOvGRpEi8y6k8YetCdS5qkM6NratIq_vcWnKKe3uO9Dx--7yF0DHjGOZPnug-2j7OMYBB7aEwgE6kAMd__1Y_QNMYNxhgwJ5jjQzSiQor5MBgjmj88JYvY2rB2de2jixfJIrny7010xia-SnIfOqd97GzwziSraI_QQaXqaKe7OkGrm-vn_C5dPt7e54tl2pKMdqmyBDQ13OIqowwYA6MYEGUloRnXAFUJlc5YaYwpTSU5FUIwpeeWUolLQyfo8svb9uXWGm2bLqi6aIPbqvBReOWKv5vGvRRr_1YAEEqB8cFwtjME_9rb2BVbF7Wta9VY38eCYs6lpMDZgJ7-Qze-D81w30CJjGPJmBiok9-RfrJ8P5R-AsVneA4</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3086709558</pqid></control><display><type>article</type><title>CNS Aspergillosis: A Downside of Corticosteroid Use</title><source>PubMed Central Open Access</source><source>PubMed Central</source><creator>Bonagiri, Pranay R ; Raman, Anjalee ; Hassan, Sharjeel ; Ramsey, Andrea</creator><creatorcontrib>Bonagiri, Pranay R ; Raman, Anjalee ; Hassan, Sharjeel ; Ramsey, Andrea</creatorcontrib><description>Glucocorticoids are ubiquitously used by physicians for a myriad of diseases. Though powerful and potentially lifesaving, sometimes the dangerous side effects are not at the forefront of our medical decision-making. By immunosuppressing patients, glucocorticoids can place patients at increased risk for not only the metabolic effects of chronic glucocorticoid use but also increased risk for opportunistic infections. Patients at increased risk include those on prolonged courses or those that require high doses. We report a case of a 34-year-old man who was initiated on glucocorticoids for an unknown rheumatologic disease and presented with generalized weakness, fatigue, nausea, and vomiting. The patient experienced a seizure, which prompted head imaging. A mass was found and eventually biopsied, which was notable for
The patient was initiated on antifungals for CNS aspergillosis and recovered.</description><identifier>ISSN: 2168-8184</identifier><identifier>EISSN: 2168-8184</identifier><identifier>DOI: 10.7759/cureus.62018</identifier><identifier>PMID: 38984001</identifier><language>eng</language><publisher>United States: Cureus Inc</publisher><subject>Abscesses ; Aspergillosis ; Biopsy ; Convulsions & seizures ; Fungi ; Hospitals ; Immunocompetence ; Infections ; Infectious Disease ; Internal Medicine ; Lung diseases ; Neurology ; Patients ; Sepsis ; Steroids</subject><ispartof>Curēus (Palo Alto, CA), 2024-06, Vol.16 (6), p.e62018</ispartof><rights>Copyright © 2024, Bonagiri et al.</rights><rights>Copyright © 2024, Bonagiri et al. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Copyright © 2024, Bonagiri et al. 2024 Bonagiri et al.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11233157/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11233157/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27923,27924,53790,53792</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38984001$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bonagiri, Pranay R</creatorcontrib><creatorcontrib>Raman, Anjalee</creatorcontrib><creatorcontrib>Hassan, Sharjeel</creatorcontrib><creatorcontrib>Ramsey, Andrea</creatorcontrib><title>CNS Aspergillosis: A Downside of Corticosteroid Use</title><title>Curēus (Palo Alto, CA)</title><addtitle>Cureus</addtitle><description>Glucocorticoids are ubiquitously used by physicians for a myriad of diseases. Though powerful and potentially lifesaving, sometimes the dangerous side effects are not at the forefront of our medical decision-making. By immunosuppressing patients, glucocorticoids can place patients at increased risk for not only the metabolic effects of chronic glucocorticoid use but also increased risk for opportunistic infections. Patients at increased risk include those on prolonged courses or those that require high doses. We report a case of a 34-year-old man who was initiated on glucocorticoids for an unknown rheumatologic disease and presented with generalized weakness, fatigue, nausea, and vomiting. The patient experienced a seizure, which prompted head imaging. A mass was found and eventually biopsied, which was notable for
The patient was initiated on antifungals for CNS aspergillosis and recovered.</description><subject>Abscesses</subject><subject>Aspergillosis</subject><subject>Biopsy</subject><subject>Convulsions & seizures</subject><subject>Fungi</subject><subject>Hospitals</subject><subject>Immunocompetence</subject><subject>Infections</subject><subject>Infectious Disease</subject><subject>Internal Medicine</subject><subject>Lung diseases</subject><subject>Neurology</subject><subject>Patients</subject><subject>Sepsis</subject><subject>Steroids</subject><issn>2168-8184</issn><issn>2168-8184</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><recordid>eNpdkM9LwzAUx4MobszdPEvBi5fOvGRpEi8y6k8YetCdS5qkM6NratIq_vcWnKKe3uO9Dx--7yF0DHjGOZPnug-2j7OMYBB7aEwgE6kAMd__1Y_QNMYNxhgwJ5jjQzSiQor5MBgjmj88JYvY2rB2de2jixfJIrny7010xia-SnIfOqd97GzwziSraI_QQaXqaKe7OkGrm-vn_C5dPt7e54tl2pKMdqmyBDQ13OIqowwYA6MYEGUloRnXAFUJlc5YaYwpTSU5FUIwpeeWUolLQyfo8svb9uXWGm2bLqi6aIPbqvBReOWKv5vGvRRr_1YAEEqB8cFwtjME_9rb2BVbF7Wta9VY38eCYs6lpMDZgJ7-Qze-D81w30CJjGPJmBiok9-RfrJ8P5R-AsVneA4</recordid><startdate>20240609</startdate><enddate>20240609</enddate><creator>Bonagiri, Pranay R</creator><creator>Raman, Anjalee</creator><creator>Hassan, Sharjeel</creator><creator>Ramsey, Andrea</creator><general>Cureus Inc</general><general>Cureus</general><scope>NPM</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20240609</creationdate><title>CNS Aspergillosis: A Downside of Corticosteroid Use</title><author>Bonagiri, Pranay R ; Raman, Anjalee ; Hassan, Sharjeel ; Ramsey, Andrea</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p263t-ae21c3d7e0f6351551da512ae92367c11fb1fc65bdddbdf9738885ac4e3390bd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Abscesses</topic><topic>Aspergillosis</topic><topic>Biopsy</topic><topic>Convulsions & seizures</topic><topic>Fungi</topic><topic>Hospitals</topic><topic>Immunocompetence</topic><topic>Infections</topic><topic>Infectious Disease</topic><topic>Internal Medicine</topic><topic>Lung diseases</topic><topic>Neurology</topic><topic>Patients</topic><topic>Sepsis</topic><topic>Steroids</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bonagiri, Pranay R</creatorcontrib><creatorcontrib>Raman, Anjalee</creatorcontrib><creatorcontrib>Hassan, Sharjeel</creatorcontrib><creatorcontrib>Ramsey, Andrea</creatorcontrib><collection>PubMed</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Curēus (Palo Alto, CA)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bonagiri, Pranay R</au><au>Raman, Anjalee</au><au>Hassan, Sharjeel</au><au>Ramsey, Andrea</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>CNS Aspergillosis: A Downside of Corticosteroid Use</atitle><jtitle>Curēus (Palo Alto, CA)</jtitle><addtitle>Cureus</addtitle><date>2024-06-09</date><risdate>2024</risdate><volume>16</volume><issue>6</issue><spage>e62018</spage><pages>e62018-</pages><issn>2168-8184</issn><eissn>2168-8184</eissn><abstract>Glucocorticoids are ubiquitously used by physicians for a myriad of diseases. Though powerful and potentially lifesaving, sometimes the dangerous side effects are not at the forefront of our medical decision-making. By immunosuppressing patients, glucocorticoids can place patients at increased risk for not only the metabolic effects of chronic glucocorticoid use but also increased risk for opportunistic infections. Patients at increased risk include those on prolonged courses or those that require high doses. We report a case of a 34-year-old man who was initiated on glucocorticoids for an unknown rheumatologic disease and presented with generalized weakness, fatigue, nausea, and vomiting. The patient experienced a seizure, which prompted head imaging. A mass was found and eventually biopsied, which was notable for
The patient was initiated on antifungals for CNS aspergillosis and recovered.</abstract><cop>United States</cop><pub>Cureus Inc</pub><pmid>38984001</pmid><doi>10.7759/cureus.62018</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2168-8184 |
| ispartof | Curēus (Palo Alto, CA), 2024-06, Vol.16 (6), p.e62018 |
| issn | 2168-8184 2168-8184 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11233157 |
| source | PubMed Central Open Access; PubMed Central |
| subjects | Abscesses Aspergillosis Biopsy Convulsions & seizures Fungi Hospitals Immunocompetence Infections Infectious Disease Internal Medicine Lung diseases Neurology Patients Sepsis Steroids |
| title | CNS Aspergillosis: A Downside of Corticosteroid Use |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T05%3A16%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=CNS%20Aspergillosis:%20A%20Downside%20of%20Corticosteroid%20Use&rft.jtitle=Cur%C4%93us%20(Palo%20Alto,%20CA)&rft.au=Bonagiri,%20Pranay%20R&rft.date=2024-06-09&rft.volume=16&rft.issue=6&rft.spage=e62018&rft.pages=e62018-&rft.issn=2168-8184&rft.eissn=2168-8184&rft_id=info:doi/10.7759/cureus.62018&rft_dat=%3Cproquest_pubme%3E3077993175%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3086709558&rft_id=info:pmid/38984001&rfr_iscdi=true |